The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

β-Glucuronidase Enzymes-Global Market Insights and Sales Trends 2025

β-Glucuronidase Enzymes-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1806740

No of Pages : 101

Synopsis
β-Glucuronidase (GUSB) is an important lysosomal enzyme involved in the degradation of glucuronate-containing glycosaminoglycan. The deficiency of GUSB causes mucopolysaccharidosis type VII (MPSVII), leading to lysosomal storage in the brain.
The global β-Glucuronidase Enzymes market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of β-Glucuronidase Enzymes in various end use industries. The expanding demands from the Biopharmaceutical Companies, Hospitals, Bioscience Research Institutions and Others, are propelling β-Glucuronidase Enzymes market. Above 90%, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Above 95% segment is estimated at % CAGR for the next seven-year period.
In terms of regions, North America is expected to remain the largest market during the forecast period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for β-Glucuronidase Enzymes, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global β-Glucuronidase Enzymes market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global β-Glucuronidase Enzymes market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, β-Glucuronidase Enzymes sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of β-Glucuronidase Enzymes covered in this report include Thermo Fisher Scientific, Bio-Rad, R&D Systems, Novus Biologicals, Lifespan Biosciences, Abcam, Boster Bio, Santa Cruz Biotechnology and RayBiotech, etc.
The global β-Glucuronidase Enzymes market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Bio-Rad
R&D Systems
Novus Biologicals
Lifespan Biosciences
Abcam
Boster Bio
Santa Cruz Biotechnology
RayBiotech
Abbexa Ltd
Proteintech
Genetex
Biobyt
Aviva Systems Biology
Global β-Glucuronidase Enzymes market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global β-Glucuronidase Enzymes market, Segment by Type:
Above 90%
Above 95%
Above 99%
Others
Global β-Glucuronidase Enzymes market, by Application
Biopharmaceutical Companies
Hospitals
Bioscience Research Institutions
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of β-Glucuronidase Enzymes companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of β-Glucuronidase Enzymes
1.1 β-Glucuronidase Enzymes Market Overview
1.1.1 β-Glucuronidase Enzymes Product Scope
1.1.2 β-Glucuronidase Enzymes Market Status and Outlook
1.2 Global β-Glucuronidase Enzymes Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global β-Glucuronidase Enzymes Market Size by Region (2018-2029)
1.4 Global β-Glucuronidase Enzymes Historic Market Size by Region (2018-2023)
1.5 Global β-Glucuronidase Enzymes Market Size Forecast by Region (2024-2029)
1.6 Key Regions, β-Glucuronidase Enzymes Market Size (2018-2029)
1.6.1 North America β-Glucuronidase Enzymes Market Size (2018-2029)
1.6.2 Europe β-Glucuronidase Enzymes Market Size (2018-2029)
1.6.3 Asia-Pacific β-Glucuronidase Enzymes Market Size (2018-2029)
1.6.4 Latin America β-Glucuronidase Enzymes Market Size (2018-2029)
1.6.5 Middle East & Africa β-Glucuronidase Enzymes Market Size (2018-2029)
2 β-Glucuronidase Enzymes Market by Type
2.1 Introduction
2.1.1 Above 90%
2.1.2 Above 95%
2.1.3 Above 99%
2.1.4 Others
2.2 Global β-Glucuronidase Enzymes Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global β-Glucuronidase Enzymes Historic Market Size by Type (2018-2023)
2.2.2 Global β-Glucuronidase Enzymes Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America β-Glucuronidase Enzymes Revenue Breakdown by Type (2018-2029)
2.3.2 Europe β-Glucuronidase Enzymes Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific β-Glucuronidase Enzymes Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America β-Glucuronidase Enzymes Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa β-Glucuronidase Enzymes Revenue Breakdown by Type (2018-2029)
3 β-Glucuronidase Enzymes Market Overview by Application
3.1 Introduction
3.1.1 Biopharmaceutical Companies
3.1.2 Hospitals
3.1.3 Bioscience Research Institutions
3.1.4 Others
3.2 Global β-Glucuronidase Enzymes Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global β-Glucuronidase Enzymes Historic Market Size by Application (2018-2023)
3.2.2 Global β-Glucuronidase Enzymes Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America β-Glucuronidase Enzymes Revenue Breakdown by Application (2018-2029)
3.3.2 Europe β-Glucuronidase Enzymes Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific β-Glucuronidase Enzymes Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America β-Glucuronidase Enzymes Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa β-Glucuronidase Enzymes Revenue Breakdown by Application (2018-2029)
4 β-Glucuronidase Enzymes Competition Analysis by Players
4.1 Global β-Glucuronidase Enzymes Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in β-Glucuronidase Enzymes as of 2022)
4.3 Date of Key Players Enter into β-Glucuronidase Enzymes Market
4.4 Global Top Players β-Glucuronidase Enzymes Headquarters and Area Served
4.5 Key Players β-Glucuronidase Enzymes Product Solution and Service
4.6 Competitive Status
4.6.1 β-Glucuronidase Enzymes Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Profile
5.1.2 Thermo Fisher Scientific Main Business
5.1.3 Thermo Fisher Scientific β-Glucuronidase Enzymes Products, Services and Solutions
5.1.4 Thermo Fisher Scientific β-Glucuronidase Enzymes Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Scientific Recent Developments
5.2 Bio-Rad
5.2.1 Bio-Rad Profile
5.2.2 Bio-Rad Main Business
5.2.3 Bio-Rad β-Glucuronidase Enzymes Products, Services and Solutions
5.2.4 Bio-Rad β-Glucuronidase Enzymes Revenue (US$ Million) & (2018-2023)
5.2.5 Bio-Rad Recent Developments
5.3 R&D Systems
5.3.1 R&D Systems Profile
5.3.2 R&D Systems Main Business
5.3.3 R&D Systems β-Glucuronidase Enzymes Products, Services and Solutions
5.3.4 R&D Systems β-Glucuronidase Enzymes Revenue (US$ Million) & (2018-2023)
5.3.5 Novus Biologicals Recent Developments
5.4 Novus Biologicals
5.4.1 Novus Biologicals Profile
5.4.2 Novus Biologicals Main Business
5.4.3 Novus Biologicals β-Glucuronidase Enzymes Products, Services and Solutions
5.4.4 Novus Biologicals β-Glucuronidase Enzymes Revenue (US$ Million) & (2018-2023)
5.4.5 Novus Biologicals Recent Developments
5.5 Lifespan Biosciences
5.5.1 Lifespan Biosciences Profile
5.5.2 Lifespan Biosciences Main Business
5.5.3 Lifespan Biosciences β-Glucuronidase Enzymes Products, Services and Solutions
5.5.4 Lifespan Biosciences β-Glucuronidase Enzymes Revenue (US$ Million) & (2018-2023)
5.5.5 Lifespan Biosciences Recent Developments
5.6 Abcam
5.6.1 Abcam Profile
5.6.2 Abcam Main Business
5.6.3 Abcam β-Glucuronidase Enzymes Products, Services and Solutions
5.6.4 Abcam β-Glucuronidase Enzymes Revenue (US$ Million) & (2018-2023)
5.6.5 Abcam Recent Developments
5.7 Boster Bio
5.7.1 Boster Bio Profile
5.7.2 Boster Bio Main Business
5.7.3 Boster Bio β-Glucuronidase Enzymes Products, Services and Solutions
5.7.4 Boster Bio β-Glucuronidase Enzymes Revenue (US$ Million) & (2018-2023)
5.7.5 Boster Bio Recent Developments
5.8 Santa Cruz Biotechnology
5.8.1 Santa Cruz Biotechnology Profile
5.8.2 Santa Cruz Biotechnology Main Business
5.8.3 Santa Cruz Biotechnology β-Glucuronidase Enzymes Products, Services and Solutions
5.8.4 Santa Cruz Biotechnology β-Glucuronidase Enzymes Revenue (US$ Million) & (2018-2023)
5.8.5 Santa Cruz Biotechnology Recent Developments
5.9 RayBiotech
5.9.1 RayBiotech Profile
5.9.2 RayBiotech Main Business
5.9.3 RayBiotech β-Glucuronidase Enzymes Products, Services and Solutions
5.9.4 RayBiotech β-Glucuronidase Enzymes Revenue (US$ Million) & (2018-2023)
5.9.5 RayBiotech Recent Developments
5.10 Abbexa Ltd
5.10.1 Abbexa Ltd Profile
5.10.2 Abbexa Ltd Main Business
5.10.3 Abbexa Ltd β-Glucuronidase Enzymes Products, Services and Solutions
5.10.4 Abbexa Ltd β-Glucuronidase Enzymes Revenue (US$ Million) & (2018-2023)
5.10.5 Abbexa Ltd Recent Developments
5.11 Proteintech
5.11.1 Proteintech Profile
5.11.2 Proteintech Main Business
5.11.3 Proteintech β-Glucuronidase Enzymes Products, Services and Solutions
5.11.4 Proteintech β-Glucuronidase Enzymes Revenue (US$ Million) & (2018-2023)
5.11.5 Proteintech Recent Developments
5.12 Genetex
5.12.1 Genetex Profile
5.12.2 Genetex Main Business
5.12.3 Genetex β-Glucuronidase Enzymes Products, Services and Solutions
5.12.4 Genetex β-Glucuronidase Enzymes Revenue (US$ Million) & (2018-2023)
5.12.5 Genetex Recent Developments
5.13 Biobyt
5.13.1 Biobyt Profile
5.13.2 Biobyt Main Business
5.13.3 Biobyt β-Glucuronidase Enzymes Products, Services and Solutions
5.13.4 Biobyt β-Glucuronidase Enzymes Revenue (US$ Million) & (2018-2023)
5.13.5 Biobyt Recent Developments
5.14 Aviva Systems Biology
5.14.1 Aviva Systems Biology Profile
5.14.2 Aviva Systems Biology Main Business
5.14.3 Aviva Systems Biology β-Glucuronidase Enzymes Products, Services and Solutions
5.14.4 Aviva Systems Biology β-Glucuronidase Enzymes Revenue (US$ Million) & (2018-2023)
5.14.5 Aviva Systems Biology Recent Developments
6 North America
6.1 North America β-Glucuronidase Enzymes Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe β-Glucuronidase Enzymes Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific β-Glucuronidase Enzymes Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America β-Glucuronidase Enzymes Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa β-Glucuronidase Enzymes Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 β-Glucuronidase Enzymes Market Dynamics
11.1 β-Glucuronidase Enzymes Industry Trends
11.2 β-Glucuronidase Enzymes Market Drivers
11.3 β-Glucuronidase Enzymes Market Challenges
11.4 β-Glucuronidase Enzymes Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’